E-LIB Suche - Ergebnisse für: Saigí, Maria

1

MYC activation impairs cell-intrinsic IFNγ signaling and co..:

Alburquerque Bejar, Juan J ; Navajas Chocarro, Pablo ; Saigí, Maria...
Reproducció del document publicat a: https://doi.org/10.1016/j.xcrm.2023.101006. , 2023

Link: http://hdl.handle.net/24..

2

Characterization of a cohort of metastatic lung cancer pati..:

Notario, Lucía ; Cucurull, Marc ; Cerdà, Gabriela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616300/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Biological and clinical perspectives of the actionable gene..:

Saigí, Maria ; Carcereny, Enric ; Morán, Teresa...
Instituto de Salud Carlos III JR20/00015. , 2022

Link: https://ddd.uab.cat/reco..

4

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: ..:

Cucurull, Marc ; Notario, Lucia ; Sanchez-Cespedes, Montse...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793278/. , 2022

Link: http://www.ncbi.nlm.nih...

5

MET-induced CD73 restrains STING-mediated immunogenicity of..:

Yoshida, Ryohei ; Saigi, Maria ; Tani, Tetsuo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627131/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Efficacy of CDK4/6 inhibitors in preclinical models of mali..:

Aliagas, Elisabet ; Alay, Ania ; Martínez Iniesta, María...
Versió postprint del document publicat a: https://doi.org/10.1038/s41416-021-01547-y. , 2021

Link: http://hdl.handle.net/24..

7

Intrinsic immunogenicity of small cell lung carcinoma revea..:

Mahadevan, Navin R ; Knelson, Erik H ; Wolff, Jacquelyn O...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338750/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Efficacy of CDK4/6 inhibitors in preclinical models of mali..:

Aliagas, Elisabet ; Alay, Ania ; Martínez-Iniesta, Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576019/. , 2021

Link: http://www.ncbi.nlm.nih...

9

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and K..:

Romero, Octavio A ; Vilarrubi, Andrea ; Alburquerque-Béjar, Juan Jos...
European Commission. Horizon 2020 799850. , 2021

Link: https://ddd.uab.cat/reco..

10

Efficacy of CDK4/6 inhibitors in preclinical models of mali..:

Aliagas, Elisabet ; Alay, Ania ; Martínez-Iniesta, Maria...
info:eu-repo/grantAgreement/EC/H2020/766214/. , 2021

Link: https://zenodo.org/recor..

11

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and K..:

Romero, Octavio A ; Vilarrubi, Andrea ; Alburquerque Bejar, Juan J...
Reproducció del document publicat a: https://doi.org/10.1038/s41467-021-24618-3. , 2021

Link: http://hdl.handle.net/24..

12

Prognostic model of long-term advanced stage (IIIB-IV) EGFR..:

Gutiérrez, Lourdes ; Royuela, Ana ; Carcereny, Enric...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406921/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors :..:

Cucurull, Marc ; Notario, Lucia ; Sanchez-Cespedes, Montse...
Instituto de Salud Carlos III JR20/00015. , 2021

Link: https://ddd.uab.cat/reco..

14

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and K..:

Romero, Octavio A ; Vilarrubi, Andrea ; Alburquerque-Bejar, Juan J...
http://hdl.handle.net/10668/18200. , 2021

Link: http://hdl.handle.net/10..

15

Prognostic model of long-term advanced stage (IIIB-IV) EGFR..:

Gutiérrez, Lourdes ; Royuela, Ana ; Carcereny, Enric...
http://hdl.handle.net/10668/18484. , 2021

Link: http://hdl.handle.net/10..